These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31111428)

  • 1. Plasma Replacement Therapy for Alzheimer's Disease.
    Ding XL; Lei P
    Neurosci Bull; 2020 Jan; 36(1):89-90. PubMed ID: 31111428
    [No Abstract]   [Full Text] [Related]  

  • 2. Succinylated gelatin as partial fluid replacement in chronic therapeutic plasma exchange.
    Gregor-MacGregor S; Pusey CD
    J Clin Apher; 1992; 7(3):124-5. PubMed ID: 1286990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic usefulness of concentrated plasma produced locally].
    Orlovskiĭ T; Vitchak V; Klos M; Badovskiĭ A
    Voen Med Zh; 1983 Sep; (9):61-3. PubMed ID: 6649496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic plasma exchange in the hemolytic-uremic syndrome].
    Bambauer R; Jutzler GA; Jesberger HJ; Graf N; Limbach HG; Sitzmann FC; Keuth U
    Dtsch Med Wochenschr; 1988 Aug; 113(31-32):1245-9. PubMed ID: 3042348
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study.
    Boada M; Ramos-Fernández E; Guivernau B; Muñoz FJ; Costa M; Ortiz AM; Jorquera JI; Núñez L; Torres M; Páez A
    Neurologia; 2016 Sep; 31(7):473-81. PubMed ID: 25023458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the efficacy and tolerability of 2 plasma substitutes used as vascular-loading solutions during plasma exchange].
    Bombail-Girard D; Boulechfar H; Tangre M; Landillon N; Bussel A
    Ann Med Interne (Paris); 1990; 141(7):611-4. PubMed ID: 2085241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    Cuberas-Borrós G; Roca I; Boada M; Tárraga L; Hernández I; Buendia M; Rubio L; Torres G; Bittini Á; Guzmán-de-Villoria JA; Pujadas F; Torres M; Núñez L; Castell J; Páez A
    J Alzheimers Dis; 2018; 61(1):321-332. PubMed ID: 29154283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium.
    Goss GA; Weinstein R
    J Clin Apher; 1999; 14(3):114-21. PubMed ID: 10540365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of animal models for therapy of Alzheimer's disease].
    Shoji M
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):27-9. PubMed ID: 12649842
    [No Abstract]   [Full Text] [Related]  

  • 10. Are we prepared to deal with the Alzheimer's disease pandemic?
    Holtzman JL
    Clin Pharmacol Ther; 2010 Oct; 88(4):563-5. PubMed ID: 20703225
    [No Abstract]   [Full Text] [Related]  

  • 11. 14 years of therapeutic plasma exchange in France.
    Korach JM; Petitpas D; Poiron L; Vincent N; Berger PH; Chillet P;
    Transfus Apher Sci; 2001 Aug; 25(1):73-7. PubMed ID: 11791768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coping with shortage of plasma and albumin: a strategy for artificial liver].
    HUANG JR; YUAN WX
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):330-1. PubMed ID: 19497194
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization.
    Boada M; Ortiz P; Anaya F; Hernández I; Muñoz J; Núñez L; Olazarán J; Roca I; Cuberas G; Tárraga L; Buendia M; Pla RP; Ferrer I; Páez A
    Drug News Perspect; 2009; 22(6):325-39. PubMed ID: 19771322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The next steps in curing Alzheimer's disease.
    van Leeuwen FW
    Prog Mol Biol Transl Sci; 2019; 168():219-221. PubMed ID: 31699316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The problems of plasma substitution in performing therapeutic plasmapheresis (an evaluation of the efficacy of plasma substitute media and the methods for obtaining them)].
    Ryzhko VV; Gorodetskiĭ VM; Aleksanian MZh; Margulis EIa
    Ter Arkh; 1989; 61(7):60-5. PubMed ID: 2588145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal polycythaemia: effect of partial dilutional exchange transfusion with human albumin on whole blood viscosity.
    Levy I; Merlob P; Ashkenazi S; Reisner SH
    Eur J Pediatr; 1990 Feb; 149(5):354-5. PubMed ID: 2311632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in a single center: Ibni Sina experience.
    Arslan O; Arat M; Tek I; Ayyildiz E; Ilhan O
    Transfus Apher Sci; 2004 Jun; 30(3):181-4. PubMed ID: 15172620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging. Alzheimer's disease.
    Harv Womens Health Watch; 1999 Mar; 6(7):2-4. PubMed ID: 10066318
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferons: A molecular switch between damage and repair in ageing and Alzheimer's disease.
    Gorlé N; Vandenbroucke RE
    Mech Ageing Dev; 2019 Oct; 183():111148. PubMed ID: 31541624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.